The phrase "patient-centered care" is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the ...
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain ...
New op-ed published by leaders from the Women’s Alzheimer’s Movement at Cleveland Clinic, Alzheimer’s Research UK and the ...
The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...
A medical communication agency, MedThink SciCom breaks from conventional wisdom to transform scientific exchange. We provide insight generation, strategy and story development, data dissemination, ...
AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...
Cherry, a full-service creative healthcare agency, has appointed Peter Henshaw as Managing Director. Henshaw will be ...
Bristol Myers Squibb’s New Drug Application (NDA) for mezigdomide has been accepted by the US FDA. Mezigdomide is an oral ...
Exonate has appointed Olav Hellebø as Chief Executive Officer (CEO). Hellebø brings extensive business and scientific ...
Alignment is not proven by whether teams are coordinated, it is proven by whether their combined efforts are sustained ...
Boehringer Ingelheim’s Jascayd (nerandomilast) tablets have been granted marketing authorisation by the Medicines and ...
Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a deal worth around $10.0bn. Crinetics is a global ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results